Regenicin Inc. | Balance Sheet
Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
22.50
0.50
1,361.40
226.30
27.20
11.20
Other Current Assets
66.30
2,878.50
119.20
66.20
60.60
45.30
Total Current Assets
88.80
2,879.00
1,480.60
292.60
87.80
56.40
Long-Term Note Receivable
-
-
-
67.30
-
-
Intangible Assets
7.50
7.50
-
-
-
-
Total Assets
96.30
2,886.50
1,480.60
359.80
87.80
56.40
ST Debt & Current Portion LT Debt
929.80
797.20
270.00
175.00
175.00
Accounts Payable
1,392.50
1,393.60
360.20
262.90
281.00
Other Current Liabilities
1,475.00
2,212.30
1,618.40
1,389.90
2,073.30
Total Current Liabilities
3,797.30
4,403.10
2,248.70
1,827.80
2,529.20
Other Liabilities
438.80
-
-
-
-
Total Liabilities
4,236.10
4,403.10
2,248.70
1,827.80
2,529.20
Common Equity (Total)
4,140.60
1,517.60
768.90
1,468.90
2,442.30
Total Shareholders' Equity
4,139.70
1,516.70
768.00
1,468.00
2,441.40
Total Equity
4,139.70
1,516.70
768.00
1,468.00
2,441.40
Liabilities & Shareholders' Equity
96.30
2,886.50
1,480.60
359.80
87.80
Preferred Stock (Carrying Value)
0.90
0.90
0.90
0.90
0.90
About Regenicin
View Profile
